Bottom line
VGHCX vs HELX: the short answer
VGHCX (Vanguard Health Care Fund) and HELX (Franklin Genomic Advancements ETF) are quite different portfolios: only about 15% of their top holdings (by weight) are shared.
VGHCX is cheaper at 0.33% vs 0.5% — a difference of $17 a year per $10,000 invested.
Over five years, VGHCX returned +6.6% a year vs −3.8% for HELX.
Updated Nov 19, 2026
VGHCX vs HELX side by side
| VGHCX | HELX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Vanguard | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.33% | 0.5% |
| Annual cost per $10k | $33 | $50 |
| 10-yr cost on $10k (prospectus) | $418 | $629 |
| Max front load | 0% | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +17.3% | +25.9% |
| 5-yr return (annualized) | +6.6% | −3.8% |
| 10-yr return (annualized) | +7.7% | — |
| Best quarter | +16.8% | +19.6% |
| Worst quarter | −12.3% | −23.7% |
| Net assets (fund) | $38.2B | $27.9M |
| Number of holdings | 97 | 63 |
| Portfolio turnover | 47% | 29% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | VGHCX | HELX | Difference |
|---|---|---|---|
| 2025 | +17.3% | +25.9% | −8.6% |
| 2024 | −1.6% | −5.1% | +3.5% |
| 2023 | +5.4% | +1.2% | +4.2% |
| 2022 | −1.1% | −37.9% | +36.8% |
| 2021 | +14.3% | +9.7% | +4.6% |
Source: Fund prospectus bar charts
Holdings overlap
5 of VGHCX's top 25 holdings also appear in HELX's top 25.
| Holding | VGHCX | HELX |
|---|---|---|
| Eli Lilly & Co | 8.61% | 2.95% |
| AstraZeneca PLC | 4.59% | 2.70% |
| Vertex Pharmaceuticals Inc | 2.36% | 2.75% |
| Regeneron Pharmaceuticals Inc | 2.14% | 1.80% |
| Argenx SE | 1.68% | 1.64% |
Source: SEC Form N-PORT
VGHCX top 10
- Eli Lilly & Co — 8.61%
- Merck & Co Inc — 5.44%
- Johnson & Johnson — 4.83%
- AstraZeneca PLC — 4.59%
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- Edwards Lifesciences Corp — 2.56%
- Intuitive Surgical Inc — 2.52%
- CVS Health Corp — 2.52%
- Cencora Inc — 2.47%
HELX top 10
- Guardant Health Inc — 9.09%
- Natera Inc — 7.46%
- Krystal Biotech Inc — 6.33%
- Ligand Pharmaceuticals Inc — 4.62%
- Adaptive Biotechnologies Corp — 3.99%
- United Therapeutics Corp — 3.51%
- Bridgebio Pharma Inc — 3.50%
- Eli Lilly & Company — 2.95%
- Twist Bioscience Corp — 2.85%
- Vertex Pharmaceuticals Inc — 2.75%
FAQ
What is the difference between VGHCX and HELX?
Which is cheaper, VGHCX or HELX?
Should I own both VGHCX and HELX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.